Hungary's Richter signs contract manufacturing deal for COVID-19 vaccine

Richter-Helm joint venture to produce Inovio's DNA vaccine

Richter buys antirheumatic drug from Mycenax

In USD 16.5 mn deal

Hungary Richter reveals response to COVID-19 pandemic

Measures introduced to protect employees and to reduce risk of any potential contagion

Hungary Richter to pay HUF 63 dividend per share

According to draft resolutions for general meeting

ANALYST VIEW - Jefferies expects market to 'like' Richter deal

Endorses spending of Vraylar cash

Hungary's Richter adds new product to gynaecological portfolio

For treatment of uterine fibroids and endometriosis

Hungary Richter to launch 'wonderdrug' on new market

Company signs exclusive license and supply agreement

EMA accepts new Richter contraceptive

To be sold in Europe and Russia

Richter is a top pick, share price may take off

Management considered overly conservative

Hungary Richter projects moderate revenue growth for 2020

Double-digit increase possible in U.S. and Western Europe

On-offs weigh on the results of Hungary's Richter

Fourth-quarter revenue rises to new record high

ANALYST VIEW - Erste raises target price for Hungary's Richter

Recommendation remains 'Accumulate'

Hungary Richter transfers shares to employee share programme

Almsot half a million shares

Richter employees may now sell their shares

Lock-up period expires

Hungarys' Richter revises 2019 estimates higher

Management turn more upbeat

Hungary Richter seen reporting record quarterly revenue

Profit expected to jump from low base

Hungary's Richter signs license and development agreement with Mycovia

For RVVC drug VT-1161

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

Rating upgraded to 'Buy' from 'Underperform'

Richter announces approval in Japan of its licensed-out biosimilar teriparatide

Hungarian drugmaker Richter projects slight growth in sales this year

With a 10% decrease in Russia and 20% in China